Cambridge Cognition (LON:COG) Hits New 1-Year High at $99.85
Cambridge Cognition Holdings Plc (LON:COG) shares reached a new 52-week high during trading on Tuesday . The company traded as high as GBX 99.85 ($1.30) and last traded at GBX 99.85 ($1.30), with a volume of 169638 shares trading hands. The stock had previously closed at GBX 90 ($1.18).
The company has a market capitalization of £36.03 million and a P/E ratio of -65.67. The company has a 50-day moving average of GBX 79 and a two-hundred day moving average of GBX 65.53.
About Cambridge Cognition (LON:COG)
Cambridge Cognition Holdings Plc, a neuroscience technology company, develops digital health solutions in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB Recruit, an online patient recruitment platform for pharmaceutical and biotechnology companies to identify qualified clinical trial participants in high-need indications, such as Alzheimer's disease; CANTAB Connect that provides digital cognitive assessment solutions for pharmaceutical clinical trials in various therapeutic areas from Phases IÂ-IV or a cognitive testing software that enhances the chances of success and minimizing the risk of failure in neuroscience research; and Cognition Kit, a digital health platform, which delivers wearable and smartphone apps for data collection to provide engaging digital health solutions for the enhancement of patient engagement, demonstration of treatment efficacy, and understanding of a disease and a patient's response to medication.
Receive News & Ratings for Cambridge Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition and related companies with MarketBeat.com's FREE daily email newsletter.